Z

Zydus Lifesciences Ltd

Pharmaceuticals

MIDCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 30 analysts offering recommendations for Zydus Lifesciences Ltd

50%

Buy

33%

Hold

17%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio24.9751.49
PB Ratio4.366.67
Dividend Yield0.31%0.52%

Understand what these metrics mean. 

About the company

Z

Zydus Lifesciences Ltd

Zydus Lifesciences Ltd is an India-based life sciences company. The Company has a pipeline for Biologics and Vaccines.

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions